Global Neuromodulation Devices and Implantable Infusion Pumps Market By Type (Spinal Cord Stimulation , Deep Brain Stimulation , Sacral Nerve Stimulation , Vagal Nerve Stimulation , Gastric Stimulation , Transcranial magnetic Stimulation , and Transcutaneous Electrical Stimulation), By Application (Parkinson's disease , Epilepsy , and Pain), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 134559
- 12-Dec
- PDF/PPT/Word
-
Report Details
The report on Neuromodulation Devices and Implantable Infusion Pumps Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global neuromodulation devices and implantable infusion pumps market is segmented on the basis of Type, Application and geography.
The worldwide market for Neuromodulation Devices and Implantable Infusion Pumps Market is expected to grow at a CAGR of roughly x.x% over the next ten years and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.
Neuromodulation Devices and Implantable Infusion Pumps Market Scope:
By type, the market is segmented into Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagal Nerve Stimulation, Gastric Stimulation, Transcranial magnetic Stimulation and Transcutaneous Electrical Stimulation. By Application, the market is divided into Parkinson’s disease, Epilepsy and Pain. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical and Greatbatch Medical.
Key Market Segments
Type
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical StimulationApplication
Parkinson’s disease
Epilepsy
PainKey Market Players included in the report:
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch MedicalReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Neuromodulation Devices and Implantable Infusion Pumps Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Neuromodulation Devices and Implantable Infusion Pumps Market, high-growth regions, and market drivers, restraints and also market chances.
The analysis covers Neuromodulation Devices and Implantable Infusion Pumps Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Neuromodulation Devices and Implantable Infusion Pumps Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Neuromodulation Devices and Implantable Infusion Pumps Market together side their company profiles, SWOT analysis, latest advancements and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
To know the Neuromodulation Devices and Implantable Infusion Pumps Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Neuromodulation Devices and Implantable Infusion Pumps sub-markets, depending on key regions (various vital states).
To analyze Neuromodulation Devices and Implantable Infusion Pumps Market concerning growth trends, prospects and also their participation in the entire sector.
To examine and study the Neuromodulation Devices and Implantable Infusion Pumps Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
Primary worldwide Neuromodulation Devices and Implantable Infusion Pumps Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market. -
Table Of Content
1. Neuromodulation Devices and Implantable Infusion Pumps Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Overview3.1. Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Spinal Cord Stimulation
4.4. Deep Brain Stimulation
4.5. Sacral Nerve Stimulation
4.6. Vagal Nerve Stimulation
4.7. Gastric Stimulation
4.8. Transcranial magnetic Stimulation
4.9. Transcutaneous Electrical Stimulation5. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-20285.1. Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Parkinson’s disease
5.4. Epilepsy
5.5. Pain6. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-20286.1. North America
6.1.1. North America Neuromodulation Devices and Implantable Infusion Pumps Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2. Europe
6.2.1. Europe Neuromodulation Devices and Implantable Infusion Pumps Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia6.4. Latin America
6.4.1. Latin America Neuromodulation Devices and Implantable Infusion Pumps Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Medtronic7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Boston Scientific Corporation7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. St.Jude Medical7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Synapse Biomedical7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Nevro Corporation7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Neuropace7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Cyberonics7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Autonomic Technologies7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Avery Biomedical7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. Greatbatch Medical7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
